T1	Participants 24 72	prevention of postoperative nausea and vomiting.
T2	Participants 191 262	two randomized, double-blind, placebo-controlled, multi-centre studies.
T3	Participants 288 385	ondansetron 1, 8 and 16 mg to placebo, and the second study compared 8 mg ondansetron to placebo.
T4	Participants 728 814	8 mg three times daily was also significantly better than placebo in the second study.
T5	Participants 815 916	Side-effects mainly consisted of constipation, headache, and asymptomatic elevation of liver enzymes.
T6	Participants 1026 1237	no clinically important benefit of the 16 mg three times daily ondansetron regimen over the 8 mg three times daily dose, therefore 8 mg three times daily is recommended as the optimal oral dose in the prevention
